---
figid: PMC3526371__nihms-424389-f0001
figlink: /pmc/articles/PMC3526371/figure/F1/
number: Figure 1
caption: 'NF-κB activation in pathogenesis and therapy of cancer. A. Canonical NF-κB
  activation is inducible by chronic exposure to bacteria, certain viral products,
  chemical promoters, carcinogens, cytotoxic agents and reactive oxygen species (ROS).
  Repeated DNA damage may result in constitutive activation of oncogenes upstream
  of the IKK complex, including EGFR, Her2, and KRAS. Intermediate kinases convey
  signals to the Inhibitor-κB complex formed by IKKα, β and γ, and IKKβ and CK2 phosphorylate
  Inhibitor-κB, marking it for ubiquitination and proteasome degradation. P105/RELA
  or cREL is processed to NF-κB1 (p50)/RELA or cREL heterodimers, which translocate
  to the nucleus and bind promoters of genes regulating proliferation, apoptosis,
  migration inflammation, angiogenesis, and innate immunity. B. Inactivation of tumor
  suppressor p53 enhances NF-κB activation. C. Non-canonical Pathway. The alternative
  pathway may be activated by other TNF family members via NIK, and involves IKKα/IKKα
  homodimers, which activate NF-κB2/p100 for processing into p52/RelB heterodimers.
  The Rel-B/p52 heterodimer then translocates into the nucleus to bind the promoters
  of genes whose products are important for the malignant phenotype in some cancers
  and B cell development and adaptive immunity. Red highlighted activators in adenocarcinoma
  include EGFR, Her2, KRAS; Inhibitors of NF-κB activation under clinical investigation
  include proteasome and IKK antagonists. Abbreviations: NF-κB, nuclear factor κB;
  IKK, Inhibitor-κB kinase; NIK, NF-κB inducing kinase; TNFR, Tumor Necrosis Factor
  Receptor; IL-1R, Interleukin 1 R; EGFR, Epidermal Growth Factor Receptor; TRAF,
  TNF receptor associated factor; TAK, transforming growth factor-beta activated kinase;
  FAK, Focal Adhesion Kinase; CK2, casein kinase 2; PI3-K, phosphatidylinositol 3-kinase;
  PDK, 3-phosphoinisitide dependent protein kinase'
pmcid: PMC3526371
papertitle: Targeting Nuclear Factor-κB in mouse models of lung adenocarcinoma.
reftext: Carter Van Waes. Cancer Discov. 2011 Aug;1(3):200-202.
pmc_ranked_result_index: '221145'
pathway_score: 0.9502208
filename: nihms-424389-f0001.jpg
figtitle: NFKB activation in pathogenesis and therapy of cancer
year: '2011'
organisms:
- Homo sapiens
ndex: ''
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC3526371__nihms-424389-f0001.html
  '@type': Dataset
  description: 'NF-κB activation in pathogenesis and therapy of cancer. A. Canonical
    NF-κB activation is inducible by chronic exposure to bacteria, certain viral products,
    chemical promoters, carcinogens, cytotoxic agents and reactive oxygen species
    (ROS). Repeated DNA damage may result in constitutive activation of oncogenes
    upstream of the IKK complex, including EGFR, Her2, and KRAS. Intermediate kinases
    convey signals to the Inhibitor-κB complex formed by IKKα, β and γ, and IKKβ and
    CK2 phosphorylate Inhibitor-κB, marking it for ubiquitination and proteasome degradation.
    P105/RELA or cREL is processed to NF-κB1 (p50)/RELA or cREL heterodimers, which
    translocate to the nucleus and bind promoters of genes regulating proliferation,
    apoptosis, migration inflammation, angiogenesis, and innate immunity. B. Inactivation
    of tumor suppressor p53 enhances NF-κB activation. C. Non-canonical Pathway. The
    alternative pathway may be activated by other TNF family members via NIK, and
    involves IKKα/IKKα homodimers, which activate NF-κB2/p100 for processing into
    p52/RelB heterodimers. The Rel-B/p52 heterodimer then translocates into the nucleus
    to bind the promoters of genes whose products are important for the malignant
    phenotype in some cancers and B cell development and adaptive immunity. Red highlighted
    activators in adenocarcinoma include EGFR, Her2, KRAS; Inhibitors of NF-κB activation
    under clinical investigation include proteasome and IKK antagonists. Abbreviations:
    NF-κB, nuclear factor κB; IKK, Inhibitor-κB kinase; NIK, NF-κB inducing kinase;
    TNFR, Tumor Necrosis Factor Receptor; IL-1R, Interleukin 1 R; EGFR, Epidermal
    Growth Factor Receptor; TRAF, TNF receptor associated factor; TAK, transforming
    growth factor-beta activated kinase; FAK, Focal Adhesion Kinase; CK2, casein kinase
    2; PI3-K, phosphatidylinositol 3-kinase; PDK, 3-phosphoinisitide dependent protein
    kinase'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - PIK3CB
  - IL1R1
  - MYD88
  - KRAS
  - IKBKG
  - PIK3CA
  - PIK3R5
  - CSNK2A1
  - LTB
  - CD40LG
  - PIK3R6
  - AKT2
  - AKT1
  - PTK2
  - AKT3
  - PIK3CD
  - NR2C2
  - REL
  - TRAF2
  - CHUK
  - IKBKB
  - PIK3R4
  - TRAF6
  - TNFRSF1A
  - PIK3R3
  - TP53
  - NFKB1
  - ERBB2
  - RELB
  - CSNK2B
  - PDK1
  - EGFR
  - PTEN
  - CSNK2A2
  - PIK3CG
  - NFKB2
  - RELA
  - Cancer
  - Lung cancer
genes:
- word: PI3-K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CB
  entrez: '5291'
- word: IL-1R
  symbol: IL1R
  source: hgnc_prev_symbol
  hgnc_symbol: IL1R1
  entrez: '3554'
- word: MYD88
  symbol: MYD88
  source: hgnc_symbol
  hgnc_symbol: MYD88
  entrez: '4615'
- word: KRAS
  symbol: KRAS
  source: hgnc_symbol
  hgnc_symbol: KRAS
  entrez: '3845'
- word: IKKY
  symbol: IKK-gamma
  source: hgnc_alias_symbol
  hgnc_symbol: IKBKG
  entrez: '8517'
- word: PI3-K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CA
  entrez: '5290'
- word: PI3-K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R5
  entrez: '23533'
- word: CK2
  symbol: CK2
  source: bioentities_symbol
  hgnc_symbol: CSNK2A1
  entrez: '1457'
- word: LTB,
  symbol: LTB
  source: hgnc_symbol
  hgnc_symbol: LTB
  entrez: '4050'
- word: CD40L,
  symbol: CD40L
  source: hgnc_alias_symbol
  hgnc_symbol: CD40LG
  entrez: '959'
- word: PI3-K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R6
  entrez: '146850'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: FAK
  symbol: FAK
  source: hgnc_alias_symbol
  hgnc_symbol: PTK2
  entrez: '5747'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: PI3-K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CD
  entrez: '5293'
- word: TAK1
  symbol: TAK1
  source: hgnc_alias_symbol
  hgnc_symbol: NR2C2
  entrez: '7182'
- word: IKK
  symbol: IKK
  source: bioentities_symbol
  hgnc_symbol: IKBKG
  entrez: '8517'
- word: CREL
  symbol: c-Rel
  source: hgnc_alias_symbol
  hgnc_symbol: REL
  entrez: '5966'
- word: TRAF2
  symbol: TRAF2
  source: hgnc_symbol
  hgnc_symbol: TRAF2
  entrez: '7186'
- word: IKK
  symbol: IKK
  source: bioentities_symbol
  hgnc_symbol: CHUK
  entrez: '1147'
- word: IKK
  symbol: IKK
  source: bioentities_symbol
  hgnc_symbol: IKBKB
  entrez: '3551'
- word: PI3-K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R4
  entrez: '30849'
- word: TRAF6
  symbol: TRAF6
  source: hgnc_symbol
  hgnc_symbol: TRAF6
  entrez: '7189'
- word: TNFR
  symbol: TNF-R
  source: hgnc_alias_symbol
  hgnc_symbol: TNFRSF1A
  entrez: '7132'
- word: PI3-K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R3
  entrez: '8503'
- word: p53
  symbol: p53
  source: hgnc_alias_symbol
  hgnc_symbol: TP53
  entrez: '7157'
- word: NF-KB1
  symbol: NF-kB1
  source: hgnc_alias_symbol
  hgnc_symbol: NFKB1
  entrez: '4790'
- word: HER2
  symbol: HER-2
  source: hgnc_alias_symbol
  hgnc_symbol: ERBB2
  entrez: '2064'
- word: Rel-B
  symbol: REL-B
  source: hgnc_alias_symbol
  hgnc_symbol: RELB
  entrez: '5971'
- word: CK2
  symbol: CK2
  source: bioentities_symbol
  hgnc_symbol: CSNK2B
  entrez: '1460'
- word: PDK1
  symbol: PDK1
  source: hgnc_symbol
  hgnc_symbol: PDK1
  entrez: '5163'
- word: RelB
  symbol: RELB
  source: hgnc_symbol
  hgnc_symbol: RELB
  entrez: '5971'
- word: EGFR,
  symbol: EGFR
  source: hgnc_symbol
  hgnc_symbol: EGFR
  entrez: '1956'
- word: PTEN
  symbol: PTEN
  source: hgnc_symbol
  hgnc_symbol: PTEN
  entrez: '5728'
- word: CK2
  symbol: CK2
  source: bioentities_symbol
  hgnc_symbol: CSNK2A2
  entrez: '1459'
- word: PI3-K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CG
  entrez: '5294'
- word: NF-KB2
  symbol: NF-kB2
  source: hgnc_alias_symbol
  hgnc_symbol: NFKB2
  entrez: '4791'
- word: RelA
  symbol: RELA
  source: hgnc_symbol
  hgnc_symbol: RELA
  entrez: '5970'
chemicals: []
diseases:
- word: Cancer
  source: ''
  identifier: ''
- word: Lung cancer
  source: ''
  identifier: ''
---
